Uruganda rwibikoresho bya Docetaxel

Docetaxel ibikoresho fatizo uruganda rwerekanwe

Ibisobanuro bigufi:

Docetaxel ni imiti yimiti ikoreshwa mu kuvura kanseri zitandukanye.Uruhare runini ni ukubuza imikurire n’ikwirakwizwa rya kanseri ubangamira inzira ya Mitose y’uturemangingo tw’ibibyimba.Docetaxel irashobora guhuza na Tubulin, bityo ikarinda polymerisation no kubora kwa microtubules muri uturemangingo twibibyimba, bityo bigira ingaruka kumikorere ya Mitose.Ibi birashobora gutuma chromosomes yingirangingo yibibyimba idashobora gutandukana no kugenda neza, amaherezo bikaviramo urupfu rwa selile.

Ohereza imeri kuri twe

Ibicuruzwa birambuye

Ibicuruzwa

Amakuru y'ibicuruzwa

Izina:Inyandiko

Numero ya CAS:114977-28-5

Ibisobanuro:99%

Ubushobozi bwo gukora

Inzira y'ibicuruzwa:Iminsi 7.

Ubushobozi bwo gutanga umusaruro:hariho ibarura, hariho inzira, kandi umusaruro mwinshi birashoboka.

Uruhare rwa docetaxel

Docetaxel irashobora gukoreshwa mu kuvura kanseri y'ibere, kanseri y'intanga, kanseri y'ibihaha, kanseri yo mu gifu, kanseri y'urura runini n'izindi kanseri. Usibye ingaruka zayo zo kurwanya ibibyimba, docetaxel ifite n'ingaruka zo kurwanya inflammatory na immunomodulatory.Ubushakashatsi bumwe bwerekanye ko docetaxel ishobora kugabanya ingaruka ziterwa no gutwika, guteza imbere T selile no gukwirakwira, bityo bitezimbere imikorere yumubiri.

Uruganda

Yunnan hande Biotechnology Co., Ltd., yashinzwe muri Kanama 1993, ni uruganda rukora ubuhanga buhanitse mu bushakashatsi no guteza imbere ibinyabuzima.Nyuma yimyaka yiterambere, hande yashyizeho sisitemu nziza yubuziranenge, igenzura ubuziranenge bwibicuruzwa ukurikije ibipimo bihanitse, kandi byongera agaciro k’umusaruro wubushobozi.Ibicuruzwa byayo byatsinze icyemezo cy’amategeko n'amabwiriza mpuzamahanga, kandi gihinduka uruganda rukora ibikoresho bibisi bituma buri wese yumva yisanzuye.